Original Research
Published on 12 Jun 2023
Zika virus-like particles (VLPs) produced in insect cells
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1181566
- 4,463 views
- 5 citations
Type at least 3 characters
376 articles
Review
Published on 12 Jun 2023
Bifunctional antibiotic hybrids: A review of clinical candidates
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1158152
- 4,119 views
- 9 citations
Original Research
Published on 07 Jun 2023
Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1182644
- 2,463 views
- 7 citations
Original Research
Published on 05 Jun 2023
A retrospective analysis of factors associated with the length of hospital stay in COVID-19 patients treated with Nirmatrelvir / Ritonavir
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1146938
- 2,673 views
- 1 citation
Original Research
Published on 30 May 2023
Evaluating the inhibitory effect of resveratrol on the multiplication of several Babesia species and Theileria equi on in vitro cultures, and Babesia microti in mice
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1192999
- 2,804 views
- 2 citations
Original Research
Published on 26 May 2023
Development of a population pharmacokinetic model of pyrazinamide to guide personalized therapy: impacts of geriatric and diabetes mellitus on clearance
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1116226
- 3,545 views
- 5 citations
Clinical Trial
Published on 23 May 2023
Safety, tolerability, pharmacokinetics, and immunogenicity of an anti-SARS-CoV-2 monoclonal antibody HFB30132A after single dose intravenous administration in healthy Chinese subjects: a phase 1, randomized, double-blind, placebo-controlled study
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1117293
- 3,249 views
- 3 citations
Mini Review
Published on 18 May 2023
An update on the development of novel antifungal agents for eumycetoma
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1165273
- 4,598 views
- 7 citations
Original Research
Published on 16 May 2023
Long-term economic evaluation of the recombinant Mycobacterium tuberculosis fusion protein (EC) test for the diagnosis of Mycobacterium tuberculosis infection
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1161526
- 2,463 views
- 2 citations
Editorial
Published on 15 May 2023
Editorial: Phytochemicals targeting autophagy in treatment of bacterial infection and malignancies
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1205764
- 1,204 views
Review
Published on 05 May 2023
Pharmacological treatment and vaccines in monkeypox virus: a narrative review and bibliometric analysis
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1149909
- 10,471 views
- 16 citations
Review
Published on 05 May 2023
Curtailing virus-induced inflammation in respiratory infections: emerging strategies for therapeutic interventions
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1087850
- 3,877 views
- 7 citations
Original Research
Published on 28 Apr 2023
Population pharmacokinetic analysis and dosing regimen optimization of teicoplanin in critically ill patients with sepsis
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1132367
- 4,995 views
- 7 citations
Review
Published on 27 Apr 2023
Low molecular weight heparin in COVID-19: benefits and concerns
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1159363
- 5,871 views
- 9 citations
Original Research
Published on 25 Apr 2023
A model-based approach for a practical dosing strategy for the short, intensive treatment regimen for paediatric tuberculous meningitis
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1055329
- 2,164 views
- 1 citation
Original Research
Published on 25 Apr 2023
Immune-enhancing activity of polysaccharides and flavonoids derived from Phellinus igniarius YASH1
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1124607
- 4,138 views
- 13 citations